Bexion Pharmaceuticals Convenes Clinical Advisory Board
FOR IMMEDIATE RELEASE Covington, KY ~ April 2, 2019 Bexion Pharmaceuticals, Inc. (Bexion) announced today that the company has assembled a Clinical Advisory Board (CAB). The CAB is comprised of Key Opinion Leaders (KOLs) in various Oncology specialties. Their purpose is to review and provide expert guidance on the overall clinical development plan, including designs and